Atopic eczema treatment now and in the future: Targeting the skin barrier and key immune mechanisms in human skin

doi:10.5314/wjd.v6.i3.42

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (27222)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

1274

WORD

439

HTML

19316

Figures (1-4)

471

Tables (1-1)

256

Sum=21756

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

1571

Download

1697

Sum=3268

Publishing Process of This Article

Item

Count

Browse

1021

Download

1177

Sum=2198

Aug 2, 2017 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Dermatology

ISSN

2218-6190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Dermatol. Aug 2, 2017; 6(3): 42-51
Published online Aug 2, 2017. doi: 10.5314/wjd.v6.i3.42

Full Size Figure Download Figure

Figure 3 Immune dysfunction in atopic eczema. This figure summaries the number of immune factors discussed in the review. Increased and decreased levels of different factors contribute to the pathogenesis atopic eczema. TLR: Toll-like receptors; hβD-2: Human beta defensin 2; S. aureus: Staphylococcus aureus; IL: Interleukin; TSLP: Thymic stromal lymphopoietin.

Citation: Bell DC, Brown SJ. Atopic eczema treatment now and in the future: Targeting the skin barrier and key immune mechanisms in human skin. World J Dermatol 2017; 6(3): 42-51
URL: https://www.wjgnet.com/2218-6190/full/v6/i3/42.htm
DOI: https://dx.doi.org/10.5314/wjd.v6.i3.42